Nick Leasure
Director
Active in New York
[javascript protected email address]

Biography

Nick Leasure is a director on Finsbury's Capital Markets and Transactions Practice. He advises companies involved in a range of situations, including friendly and contested M&A, shareholder activism defense, restructuring, crisis situations and ongoing investor relations. Assignments include:
  • M&A: Express Scripts in its pending acquisition by Cigna, McDermott in its combination with CB&I and defense against interloper Subsea 7, Aviragen in its merger with Vaxart that was contested by the CAS Group, Takeda in its proposed acquisition of Shire, Gannett in its attempted takeover of Tronc, Norfolk Southern in its takeover defense against Canadian Pacific, Family Dollar in its acquisition by Dollar Tree that was contested by Dollar General and Elliott Management, Smithfield in its acquisition by the WH Group that was contested by Starboard Value, and US Airways in its merger with American Airlines.
  • Shareholder Activism: Credit Suisse (RBR Advisors), Arconic and Citrix (Elliott Management), Buffalo Wild Wings (Marcato), Ultratech (Neuberger Berman), Volcano Corp and AeroVironment (Engaged Capital), Herbalife and Canadian Pacific (Pershing Square) and Depomed and AOL (Starboard Value). In addition, Nick has assisted a number of companies in activism preparedness exercises.
  • Restructuring: Appvion in its Chapter 11 restructuring and subsequent 363 sale to Franklin Advisers, Savient Pharmaceuticals in its 363 sale to Crealta Pharmaceuticals, Patriot Coal in its original Chapter 11 restructuring and TerraForm Power and TerraForm Global during the SunEdison Chapter 11 process.
Nick joined Finsbury in 2017 from Joele Frank. He holds an MBA from Columbia Business School and is a graduate of Muhlenberg College.
Back to Our People